LEGISLATIVE BUDGET BOARD Austin, Texas FISCAL NOTE, 83RD LEGISLATIVE REGULAR SESSION April 5, 2013 TO: Honorable John Carona, Chair, Senate Committee on Business & Commerce FROM: Ursula Parks, Director, Legislative Budget Board IN RE:SB992 by Taylor (Relating to misrepresentations in connection with certain drug testing devices or equipment; providing penalties.), Committee Report 1st House, Substituted No significant fiscal implication to the State is anticipated. The bill would amend the Penal Code to prohibit a manufacturer or seller of drug testing equipment from representing that the equipment is capable of drug testing unless it has been approved by the United States Food and Drug Administration. It is anticipated that any costs associated with the bill could be absorbed within existing resources. Local Government Impact The bill would classify any violation of the provision of the bill as a Class C misdemeanor and punishable by a fine of not more than $500. It is anticipated that any costs associated with enforcement and prosecution could be absorbed within existing resources. It is also anticipated that any revenue from fines imposed and collected would not have a significant fiscal impact. Source Agencies:302 Office of the Attorney General LBB Staff: UP, KKR, RB, EP, JM
LEGISLATIVE BUDGET BOARD
Austin, Texas
FISCAL NOTE, 83RD LEGISLATIVE REGULAR SESSION
April 5, 2013
TO: Honorable John Carona, Chair, Senate Committee on Business & Commerce FROM: Ursula Parks, Director, Legislative Budget Board IN RE:SB992 by Taylor (Relating to misrepresentations in connection with certain drug testing devices or equipment; providing penalties.), Committee Report 1st House, Substituted
TO: Honorable John Carona, Chair, Senate Committee on Business & Commerce
FROM: Ursula Parks, Director, Legislative Budget Board
IN RE: SB992 by Taylor (Relating to misrepresentations in connection with certain drug testing devices or equipment; providing penalties.), Committee Report 1st House, Substituted
Honorable John Carona, Chair, Senate Committee on Business & Commerce
Honorable John Carona, Chair, Senate Committee on Business & Commerce
Ursula Parks, Director, Legislative Budget Board
Ursula Parks, Director, Legislative Budget Board
SB992 by Taylor (Relating to misrepresentations in connection with certain drug testing devices or equipment; providing penalties.), Committee Report 1st House, Substituted
SB992 by Taylor (Relating to misrepresentations in connection with certain drug testing devices or equipment; providing penalties.), Committee Report 1st House, Substituted
No significant fiscal implication to the State is anticipated.
No significant fiscal implication to the State is anticipated.
The bill would amend the Penal Code to prohibit a manufacturer or seller of drug testing equipment from representing that the equipment is capable of drug testing unless it has been approved by the United States Food and Drug Administration. It is anticipated that any costs associated with the bill could be absorbed within existing resources.
The bill would amend the Penal Code to prohibit a manufacturer or seller of drug testing equipment from representing that the equipment is capable of drug testing unless it has been approved by the United States Food and Drug Administration. It is anticipated that any costs associated with the bill could be absorbed within existing resources.
Local Government Impact
The bill would classify any violation of the provision of the bill as a Class C misdemeanor and punishable by a fine of not more than $500. It is anticipated that any costs associated with enforcement and prosecution could be absorbed within existing resources. It is also anticipated that any revenue from fines imposed and collected would not have a significant fiscal impact.
The bill would classify any violation of the provision of the bill as a Class C misdemeanor and punishable by a fine of not more than $500. It is anticipated that any costs associated with enforcement and prosecution could be absorbed within existing resources. It is also anticipated that any revenue from fines imposed and collected would not have a significant fiscal impact.
Source Agencies: 302 Office of the Attorney General
302 Office of the Attorney General
LBB Staff: UP, KKR, RB, EP, JM
UP, KKR, RB, EP, JM